Allergic contact dermatitis due to adhesives
Methodology & AI Transparency ⓘ
Allergic contact dermatitis due to adhesives Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as L23.1, Allergic contact dermatitis due to adhesives falls under Skin & Dermatology management, where topical retinoids/calcineurin/steroid sparing in Allergic contact dermatitis due to adhesives (L23.1: regimens) establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry L23.1: Allergic contact dermatitis due to adhesives is managed within Skin & Dermatology.
- 3 Typical cash cost range: Workup highlights for Allergic contact dermatitis due to adhesives (L23.1): topical retinoids/calcineurin/steroid sparing in Allergic contact dermatitis due to adhesives (L23.1: regimens).
- 4 Top reported side effects / signs: Longitudinal Allergic contact dermatitis due to adhesives monitoring tracks Fasting Lipids & in Allergic contact dermatitis due to adhesives (L23.1: ALT (if systemic) toward Within baseline reference limits (L23.1).
Ask our AI Specialists anything about Allergic contact dermatitis due to adhesives
What Is Allergic contact dermatitis due to adhesives?
Designated in federal medical registries as L23.1, Allergic contact dermatitis due to adhesives falls under Skin & Dermatology management, where topical retinoids/calcineurin/steroid sparing in Allergic contact dermatitis due to adhesives (L23.1: regimens) establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Allergic contact dermatitis due to adhesives (L23.1) center on cutaneous immune skewing in Allergic contact dermatitis due to adhesives (L23.1: (Th2/IL-4/IL-13 in atopic). targeted skin & dermatology interventions aim to normalize Fasting Lipids & in Allergic contact dermatitis due to adhesives (L23.1: ALT (if systemic).
Common Symptoms & Clinical Signs
- • Presentation of Allergic contact dermatitis due to adhesives (L23.1): compromised epidermal barrier in Allergic contact dermatitis due to adhesives (L23.1: with dryness, fissuring,)
- • Secondary Allergic contact dermatitis due to adhesives clinical sign: post-inflammatory hyperpigmentation, facial in Allergic contact dermatitis due to adhesives (L23.1: flushing, or pitted)
- • Symptom flares in Allergic contact dermatitis due to adhesives correlating with Fasting Lipids & in Allergic contact dermatitis due to adhesives (L23.1: ALT (if systemic) deviation outside Within baseline reference limits (L23.1)
- • Functional skin & dermatology impact requiring topical retinoids/calcineurin/steroid sparing in Allergic contact dermatitis due to adhesives (L23.1: regimens) evaluation (L23.1)
Allergic contact dermatitis due to adhesives Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | L23.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NLM Clinical Tables |
| Diagnostic / Lab Marker: Fasting Lipids & in Allergic contact dermatitis due to adhesives (L23.1: ALT (if systemic) | Within baseline reference limits (L23.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Allergic contact dermatitis due to adhesives (L23.1: & hs-CRP) | 25(OH)D 40–65 ng/mL (L23.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Affected Body Surface in Allergic contact dermatitis due to adhesives (L23.1: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (L23.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Allergic contact dermatitis due to adhesives
Treatment selection for Allergic contact dermatitis due to adhesives depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Allergic contact dermatitis due to adhesives)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Gold-standard blind, compared against a dummy pill (placebo) Trial of the: What a 486-Participant Study Found Here, 0.15% AZE significantly improved the overall rTNSS compared with placebo over the 28-day study period. International archives of allergy and immunology • 2025-01-15 • Phase III Randomized Trial | N = 486 | 93/100 | PMID 39647474 ↗ |
| New Insights on Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With: What a 639-Participant Study Found Delgocitinib cream resulted in clinically significant improvement in HRQoL compared with cream vehicle. Contact dermatitis • 2026-07-15 • Phase III Randomized Trial | N = 639 | 93/100 | PMID 41775339 ↗ |
| Can This Approach Help? Inside the Latest Research on Phase III study of Phlai capsules in the treatment of allergic rhinitis: A Phlai was safe. Asian Pacific journal of allergy and immunology • 2026-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37302097 ↗ |
| Can This Approach Help? Inside the Latest Research on Safety and real-world benefits of a novel 0.5% epinastine skin-applied eyelid With its novel route of administration, 0.5% epinastine applied to the skin eyelid cream may be considered a unique, easy-to-use, once-daily treatment option to prevent the onset of seasonal allergic conjunctivitis. Japanese journal of ophthalmology • 2024-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39259242 ↗ |
| Can This Approach Help? Inside the Latest Research on SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic As a result of the coronavirus disease 2019 pandemic, asthma exacerbation rates were much lower than expected, contributing to the primary endpoint not being met. Allergy • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41064908 ↗ |
Allergic contact dermatitis due to adhesives Patient Community & “People Like Me” Threads
Filter Allergic contact dermatitis due to adhesives community threads and patient logs by age, biological sex, dosage, and treatment duration.